| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
0.632 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
TRHR |
TRHR: Thyrotropin-releasing hormone receptor |
0.632 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
MC4R |
MC4R: Melanocortin receptor 4 |
0.632 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
0.632 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.632 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.632 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.632 |
Evidence |
|
| DRD1 |
DRD1: D(1A) dopamine receptor |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.632 |
Evidence |
|
| DRD1 |
DRD1: D(1A) dopamine receptor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.632 |
Evidence |
|
| DRD1 |
DRD1: D(1A) dopamine receptor |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.632 |
Evidence |
|
| DRD1 |
DRD1: D(1A) dopamine receptor |
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
0.632 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.632 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.632 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.632 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.632 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.632 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.632 |
Evidence |
|
| TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.632 |
Evidence |
|
| EDN2 |
EDN2: Endothelin-2 precursor |
KEL |
KEL: Kell blood group glycoprotein |
0.632 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
0.632 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
0.632 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
0.632 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
0.632 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
0.632 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
0.632 |
Evidence |
|